Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
Jonathan R. Fromm, Julie A. McEarchern, Dana Kennedy, Anju Thomas, Andrei R. Shustov, Ajay K. GopalVolume:
12
Year:
2012
Language:
english
DOI:
10.1016/j.clml.2012.01.012
File:
PDF, 1.20 MB
english, 2012